Randox expands major supplier agreement with Novation

Randox Laboratories has further expanded its market presence in the United States, having been awarded a major supplier agreement with Novation, the leading health care supply chain expertise, analytics and contracting company.

The contract means Randox third party quality control products, which are widely considered to be the most accurate in the world, will now be readily available to hospital organizations across the U.S. The new contract with Novation also makes Randox the sole NOVAPLUS® manufacturer of third party controls. NOVAPLUS is the leading private-label brand of products for hospitals and offers organizations supported by Novation the best contract value on items health care organizations purchase the most.

Randox is one of the largest manufacturers of third party quality control products in the world. Quality Control is the bedrock of patient blood testing as it helps laboratories assure accuracy in their testing procedures. If errors occur during testing, this can result in misdiagnosis and inappropriate or delayed treatment, which ultimately can be life threatening for the patient.

Novation is the leading health care supply chain expertise, analytics and contracting company for the more than 100,000 members of VHA Inc. and UHC, two national health care alliances, Children's Hospital Association, an alliance of the nation's leading pediatric facilities, and Provista, LLC. Novation provides alliance members with sourcing services, as well as information and data services. Novation develops and manages competitive contracts with more than 800 suppliers.

Steven Jordan, Global Business Manager, Randox QC said:

"This agreement with Novation is a strategically important step in Randox's expansion and we are delighted that our world-leading QC products will now be available for use in many more laboratories across the U.S. I am confident that the quality and range of products available from Randox will make us stand out in the Novation supplier portfolio."


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Randox Laboratories Ltd.. (2019, June 18). Randox expands major supplier agreement with Novation. News-Medical. Retrieved on June 24, 2024 from https://www.news-medical.net/news/20140722/Randox-expands-major-supplier-agreement-with-Novation.aspx.

  • MLA

    Randox Laboratories Ltd.. "Randox expands major supplier agreement with Novation". News-Medical. 24 June 2024. <https://www.news-medical.net/news/20140722/Randox-expands-major-supplier-agreement-with-Novation.aspx>.

  • Chicago

    Randox Laboratories Ltd.. "Randox expands major supplier agreement with Novation". News-Medical. https://www.news-medical.net/news/20140722/Randox-expands-major-supplier-agreement-with-Novation.aspx. (accessed June 24, 2024).

  • Harvard

    Randox Laboratories Ltd.. 2019. Randox expands major supplier agreement with Novation. News-Medical, viewed 24 June 2024, https://www.news-medical.net/news/20140722/Randox-expands-major-supplier-agreement-with-Novation.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New Liquid ready-to-use Tumour Marker Control available now from Randox